Advertisement
Journal Home
Search for

Issue

Alert me when new journal issues are available via Request TOC Alert via emailor via Request RSS feed of current issue

previous issue next issue

Brachytherapy
Volume 5, Issue 2, Pages 63-138 (April-June 2006)
Search Within This Issue

Viewing 1-60 of 105 Next 45 Articles> Page: [1] 2

display abstract citation download email a colleague
Display:


American Brachytherapy Society 2006 Annual Meeting Program
pages 63-69
Full Text | Full-Text PDF (53 KB)


Listing of Oral and Poster Presentations of the 27th Annual Meeting of the American Brachytherapy Society: Oral Presentations
pages 70-77
Full Text | Full-Text PDF (96 KB)


Radiation dose to the internal pudendal arteries from permanent seed prostate brachytherapy as determined by time-of-flight angiography
Juanita Crook, Caitlin Gillan, Anna Kirilova, Angela Landon, Ivan Yeung, Gregory Pond
page 78
Full Text | Full-Text PDF (64 KB)


Extracapsular radiation dose annulus correlates with biochemical control in low-risk brachytherapy patients: Results of a prospective randomized trial
Gregory S. Merrick, Wayne M. Butler, Kent E. Wallner, Zachariah A. Allen, Brian C. Kurko, Richard L. Anderson, Robert Grammer, Robert W. Galbreath
page 78
Full Text | Full-Text PDF (64 KB)


GliaSite radiotherapy boost as part of initial treatment of malignant gliomas: A multi-institutional analysis
James Welsh, Arash Gabayan, Abhay Sanan, Baldassarre Stea
pages 78-79
Full Text | Full-Text PDF (79 KB)


Pretreatment PSA velocity is associated with freedom from biochemical recurrence of prostate cancer following low-dose-rate prostate brachytherapy alone
Peter J. Rossi, Micheal A. Papagikos, Peter E. Clark, W. Robert Lee
page 79
Full Text | Full-Text PDF (51 KB)


A multi-institutional Phase II trial for Cesium-131 permanent prostate brachytherapy
Bradley Prestidge, William Bice, Ines Jurkovic, Brian Moran, Donald Fuller, James Gray, David Beyer, Steven Kurtzman, John Sylvester, Amir Sadeghi
page 79
Full Text | Full-Text PDF (51 KB)


External beam radiotherapy in comparison to brachytherapy in the prevention of restenosis after femoropopliteal artery angioplasty
David Donath, Eric Therasse, Gilles Soulez, Jacques Lesperance, Marie Giroux, Jean-Claude Tardif, Vincent Oliva
pages 79-80
Full Text | Full-Text PDF (61 KB)


Intraoperative prostate brachytherapy: does real-time ultrasound-based dosimetry obviate the need for post implant dosimetry analysis? A retrospective analysis of 1,000 patients treated at Kaiser Permanente
Alireza Mahmoudieh, David Lindstad, Micheal Russo, Deepak Chabra, Mark Logsdon, Steve Workman, Derrick Koo
page 80
Full Text | Full-Text PDF (46 KB)


Decreased intra-fraction prostate motion post permanent implant relative to non-implant patients
Patrick W. McLaughlin, Vrinda Narayana, Sally Berri, Brett Miller
page 80
Full Text | Full-Text PDF (46 KB)


Correlation of dose volume parameters, rectoscopy findings and rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy
Petra Georg, Christian Kirisits, Johann Hammer, Johannes Dimopoulos, Daniel Berger, Stefan Lang, Richard Poetter
page 81
Full Text | Full-Text PDF (51 KB)


Dose volume relations in HR-CTV as predictive factors for local tumor control in MRI-based cervical cancer brachytherapy: Comparison between patients with and without recurrence
Johannes Dimopoulos, Christian Kirisits, Daniel Berger, Stefan Lang, Petra Georg, Pötter Richard
page 81
Full Text | Full-Text PDF (52 KB)


Dosimetric variations between subsequent cervic cancer brachytherapy insertions: Can we use only one MRI-based treatment plan?
Christian Kirisits, Stefan Lang, Karin Oechs, Johannes Dimopoulos, Pötter Richard
pages 81-82
Full Text | Full-Text PDF (64 KB)


Effect of dose prescription on HDR vaginal brachytherapy
Shidong Li, Ibrahim Aref, Benjamin Movsas
page 82
Full Text | Full-Text PDF (47 KB)


Vaginal dose delivered by tandem and ovoid versus tandem and ring in cervical cancer
Caroline L. Holloway, Christian Kirisits, Robert A. Cormack, Akila N. Viswanathan
page 82
Full Text | Full-Text PDF (47 KB)


HDR brachytherapy in carcinoma cervix: Rectal retractor or gauze packing?
Nikhilesh G. Patil, Vedang Murthy, Tejpal Gupta, Umesh Mahantshetty, Dayananda Sharama, S.K. Shrivastava, K.A. Dinshaw
page 82
Full Text | Full-Text PDF (47 KB)


Toxicity from bowel perforation in interstitial implants for treatment of cancers of the gynecological tract
Mini J. Elnaggar, Thomas W. Zusag, Jacob Rotmensch, Edgardo Yordan, Ross A. Abrams
page 83
Full Text | Full-Text PDF (48 KB)


Dosimetric study of an intracavitary mold applicator for high-dose-rate rectal brachytherapy treatment
Emily Poon, Slobodan Devic, Te Vuong, Frank Verhaegen
page 83
Full Text | Full-Text PDF (48 KB)


Towards HDR 252Cf brachytherapy: Shielding assessment of a linear accelerator vault
Christopher S. Melhus, Mark J. Rivard
pages 83-84
Full Text | Full-Text PDF (62 KB)


Progress on the supplement to the 2004 update of the AAPM Task Group No. 43 Report
Mark J. Rivard, Wayne M. Butler, Larry A. DeWerd, M. Saiful Huq, Geoffrey S. Ibbott, Christopher S. Melhus, Michael G. Mitch, Ravinder Nath, Jeffrey F. Williamson
page 84
Full Text | Full-Text PDF (48 KB)


4D CT dosimetric analysis of the Mayo Clinic brachytherapy technique for a cholangiocarcinoma patient
Keith M. Furutani, Robert C. Miller, Luke B. McLemore, Christopher C. Goulet, Debra H. Brinkmann, Michael G. Haddock
page 84
Full Text | Full-Text PDF (48 KB)


Comparison of inverse planning simulated annealing and graphical optimization for prostate high dose-rate brachytherapy
Raxa Sankreacha, Patrick Halina, Gerard Morton
pages 84-85
Full Text | Full-Text PDF (62 KB)


HDR inverse planning using differential evolution
David A. Silvern, Marco Zaider, Gil'ad N. Cohen, Boris Burtman
page 85
Full Text | Full-Text PDF (48 KB)


Quality assurance of seed implants using CT/MRI phantoms
Frank-Andre Siebert, Marisol De Brabandere, Christian Kirisits, Jack Venselaar
page 85
Full Text | Full-Text PDF (48 KB)


Megavoltage cone-beam CT to complement CT-based treatment planning for HDR brachytherapy
Martina Descovich, Olivier Morin, Jean-Francois Aubry, Michele Aubin, Josephine Chen, Hong Chen, I-Chow J. Hsu, Joycelyn Speight, Jean Pouliot
pages 85-86
Full Text | Full-Text PDF (65 KB)


Long-term outcome and toxicity in a Phase I/II trial using HDR multicatheter interstitial brachytherapy for T1-2 breast cancer
Seth A. Kaufman, Thomas A. DiPetrillo, Jennifer Bassett Midle, Lori Lyn Price, David E. Wazer
page 86
Full Text | Full-Text PDF (51 KB)


Androgen deprivation therapy does not impact cause-specific or overall survival following permanent prostate brachytherapy
Gregory S. Merrick, Wayne M. Butler, Kent E. Wallner, Robert W. Galbreath, Zachariah A. Allen, Edward Adamovich
page 86
Full Text | Full-Text PDF (51 KB)


Vienna experience in 145 cervical cancer patients treated by systematic MRI-based intracavitary±interstitial brachytherapy from 1998-2003: Impact on local control
Richard Potter, Johannes Dimopoulos, Christian Kirisits, Petra Georg, Thomas Knocke, Claudia Waldhausl, Hajo Weitmann, Alexander Reinthaller, Stefan Wachter
pages 86-87
Full Text | Full-Text PDF (68 KB)


The meaning of prescription dose and D90 in permanent seed prostate brachytherapy
Wayne M. Butler, Gregory S. Merrick, Kent E. Wallner
page 87
Full Text | Full-Text PDF (54 KB)


Persistent seroma after intraoperative placement of MammoSite for APBI: Incidence, pathological anatomy, and contributing factors
Suzanne B. Evans, Seth A. Kaufman, Lori Lyn Price, Gene A. Cardarelli, Thomas Dipetrillo, David E. Wazer
page 87
Full Text | Full-Text PDF (53 KB)


Interstitial high-dose-rate (HDR) brachytherapy for early stage breast cancer
Rufus J. Mark, Paul J. Anderson, Thomas R. Neumann, Murali Nair, Scott Akins
pages 87-88
Full Text | Full-Text PDF (68 KB)


Pilot study evaluating early tolerance in patients undergoing accelerated partial breast irradiation (APBI) treated with MammoSite® using a two-day dose schedule
Michelle Wallace, Alvaro A. Martinez, Mihai Ghilezan, Peter Chen, Pamelal Benitez, E. Brown, Frank Vicini
page 88
Full Text | Full-Text PDF (51 KB)


Acute effects of partial breast brachytherapy using the MammoSite catheter vs whole breast external beam radiotherapy: Experience in a community hospital
Christopher D. Koprowski, Diana Dickson-Witmer, Emily Penman, Michael Sorensen, Sarah Sammons
page 88
Full Text | Full-Text PDF (51 KB)


Intraoperative radiation therapy for breast cancer: Early cosmetic results
Kathryn Beal, Beryl McCormick, Patrick I. Borgen, Michael J. Zelefsky, Jane Fey, Jessica Goldberg, Virgilio Sacchini
pages 88-89
Full Text | Full-Text PDF (64 KB)


Multi-catheter versus balloon breast brachytherapy: Is one method dosimetrically superior?
Rakesh R. Patel, Rupak K. Das
page 89
Full Text | Full-Text PDF (48 KB)


Interim report of a permanent breast 103Pd seed implant (PBSI) Phase I/II trial for accelerated partial breast irradiation
Jean-Philippe Pignol, Brian Keller, Eileen Rakovitch, Raxa Sankreacha, Gregory Czarnota
page 89
Full Text | Full-Text PDF (48 KB)


The prognostic value of percent positive biopsies in intermediate to high risk prostate cancer treated with brachytherapy and supplemental beam radiotherapy
Rizwan D. Nurani, Kent E. Wallner, Gregory S. Merrick, Peter Orio, Jeffery Virgin, Lawrence True
pages 89-90
Full Text | Full-Text PDF (63 KB)


Interstitial high-dose-rate (HDR) brachytherapy as monotherapy for early stage prostate cancer
Rufus J. Mark, Scott Akins, Paul J. Anderson, Thomas R. Neumann, Murali Nair
page 90
Full Text | Full-Text PDF (50 KB)


Results of primary treatment of small or medium sized uveal melanoma with custom-made Nag Iodine-125 eye plaque: The Ohio State University experience with 119 patients
Moataz N. El-Ghamry, Subir Nag, Aral Sezginis, Robert Chambers, Frederick Davidorf
page 90
Full Text | Full-Text PDF (50 KB)


Transperineal implantation of hyaluronic acid in the anterior peri-rectal fat as protector to the rectal wall from radiation delivered with either intensity modulated brachytherapy or EBRT for prostate cancer patients
Pedro Prada, Alvaro Martinez, Jose Fernandez, Angeles de la Rua, Herminio Gonzalez, Jose Manuel
page 91
Full Text | Full-Text PDF (50 KB)


Preliminary analysis of the ProQura multi-institutional prostate brachytherapy dosimetry database
Peter D. Grimm, Gregory S. Merrick, Wayne M. Butler, John C. Blasko, John E. Sylvester, Zachariah A. Allen, Usman-ul-Haq Chaudhry, Anthony Mazza
page 91
Full Text | Full-Text PDF (50 KB)


Cholangiocarcinoma: The impact of endobiliary high-dose-rate (HDR) brachytherapy dose response on survival
Matthew Biagioli, B-Chen Wen, Brandon Patton, Caroline Hoffman, Mark Harvey
page 91
Full Text | Full-Text PDF (50 KB)


A quality of life (QOL) assessment of prostate cancer patients undergoing different radiation treatment modalities
K. Saputo, A. Calcaterra, G. Boyea, Michelle Wallace, Mamtha Balasubramaniam, Alvaro Martinez
page 92
Full Text | Full-Text PDF (49 KB)


Interstitial implant alone with or without external beam radiation therapy for intermediate risk localized prostate cancer: Patterns of Care Study in the United States
Steven J. Frank, John C. Blasko, John E. Sylvester, Deborah A. Kuban, Brian J. Moran, Kent E. Wallner, Robyn Vera, Gregory S. Merrick, Anthony L. Zietman, Mack Roach, Dan Clark, Bradley R. Prestidge, Louis Potters, Jeff M. Michalski, David C. Beyer, W. Robert Lee, Richard G. Stock, Brian J. Davis, Mark D. Hurwitz, Peter D. Grimm
page 92
Full Text | Full-Text PDF (49 KB)


Re-irradiation with temporary Iridium-192 high-dose-rate prostate brachytherapy for recurrent prostate cancer patients who failed external beam radiation therapy and/or prostate seed brachytherapy
Lawrence B. Tena, Robert A. Ivker, J.P. Tracy
pages 92-93
Full Text | Full-Text PDF (63 KB)


Temporal relationship between colorectal cancer and clinically localized prostate cancer in patients managed with permanent interstitial brachytherapy
Sarah Gutman, Gregory S. Merrick, Wayne M. Butler, Kent E. Wallner, Zachariah A. Allen, Robert W. Galbreath, Edward Adamovich
page 93
Full Text | Full-Text PDF (49 KB)


Mammographic surveillance after MammoSite breast brachytherapy: Analysis of architectural patterns and additional interventions
Anthony E. Dragun, Joseph M. Jenrette, Thomas L. Pope, Susan J. Ackerman, Abid Irshad
page 93
Full Text | Full-Text PDF (49 KB)


Quality of life (qQOL), patient satisfaction and cosmesis following partial breast irradiation (PBRT) with balloon brachytherapy
Kevin Albuquerque, Linda Janusek, Herbert Mathews, Linda Millbrandt, Sheryl Gabram
pages 93-94
Full Text | Full-Text PDF (61 KB)


A quantitative analysis of dose reductions due to a radiopaque iodine-based contrast solution in Ir-192 HDR MammoSite balloon: Monte Carlo calculations, TLD, MOSFET and ion-chamber measurements
E. Ishmael Parsai, Zhengdong Zhang
page 94
Full Text | Full-Text PDF (48 KB)


MammoSite catheter HDR brachytherapy for patients who refuse mastectomy for localized breast cancer after prior radiation
Amrita G. Sawhney, Mary Katherine Hayes, Alexander Swistel, Syed Hoda, Dattatreyudu Nori
page 94
Full Text | Full-Text PDF (48 KB)


Three-dimensional dosimetry and Q/A in multi-catheter APBI
Imran Zoberi, Jacqueline Esthappan, Zuofeng Li
pages 94-95
Full Text | Full-Text PDF (60 KB)


LDR brachytherapy implants as a boost in early stage breast cancer in women with cilastic implants
Ly Do, Nisar Syed, Ajmel Puthawala
page 95
Full Text | Full-Text PDF (46 KB)


Treatment of early breast cancer using MammoSite in a community-based practice with emphasis on patients' acceptance
Beatriz E. Amendola, Cristina Lopez-Penalver, Marco A. Amendola
page 95
Full Text | Full-Text PDF (45 KB)


Initial cosmesis and toxicity results with high-dose-rate intracavitary brachytherapy for early stage breast cancer
Zain A. Husain, A.M. Nisar Syed, Ajmel Puthawala, Joel Cherlow, Steve Damore, Anil Sharma
page 95
Full Text | Full-Text PDF (45 KB)


Accuracy of postimplant seed reconstruction studied with a CT- and MRI-compatible prostate phantom
Marisol De Brabandere, Christian Kirisits, Frank-Andre Siebert
page 96
Full Text | Full-Text PDF (50 KB)


DVH analysis and quality assurance of high-dose-rate (HDR) brachytherapy for prostate cancer
Murali Nair, Rufus Mark, Paul Anderson, Thomas Neumann, David White, Stephen Gurley
page 96
Full Text | Full-Text PDF (50 KB)


Clinical benefits of a class solution for inversely planned high-dose-rate prostate brachytherapy
Etienne Lessard, I-Chow J. Hsu, Jean Pouliot
pages 96-97
Full Text | Full-Text PDF (65 KB)


In vivo MOSFET detector used in the post-operative dose assessment of I-125 prostate implants
Ines Jurkovic, Amir Sadeghi, Bradley Prestidge, E. Walker, M. Simms, William S. Bice
page 97
Full Text | Full-Text PDF (49 KB)


Dose perturbation in the presence of vaginal cylinder with Ir-192 HDR source: A radiochromic film dosimetry study
Sou-Tung Chiu-Tsao, Nirah Shah, Lin Wang, Manjeet Chadha, Louis Harrison
page 97
Full Text | Full-Text PDF (49 KB)


Accuracy of DVH calculation in modern brachytherapy treatment planning systems
Christian Kirisits, Frank-Andre Siebert, Marisol De Brabandere, Taran Paulsen Hellebust, Jack L.M. Venselaar
pages 97-98
Full Text | Full-Text PDF (65 KB)

display abstract citation download email a colleague
Display:

Viewing 1-60 of 105 Next 45 Articles> Page: [1] 2
Advertisement